“Our 12-lead AIMIGo technology, which is part of our granted patent, offers the potential to bring a level of diagnostic accuracy consistent with the current 12-lead ECG standard of care.

By elevating patch monitor technology with a synthesized 12-lead ECG, HeartBeam can aid physicians in both arrhythmia detection and ACS diagnosis including myocardial infarction (heart attack) and ...

Data from the pilot study presented at the AHA Scientific Sessions, which also supported the FDA submission, found similar performance of HeartBeam’s synthesized 12-lead ECG waveforms compared ...

Some clinicians say that testing for occlusion myocardial infarction ... then it makes sense because the standard 12-lead EKG is a little bit limited,” he explained. “Personally, though, I think from ...

A 56-year-old woman with COVID-19 presents to a rural emergency department with complaints of severe substernal chest pain.